Canvas 1839 products are formulated with a focus on high bioavailability, and are completely non-psychoactive.
AUSTIN, Texas (PRWEB) May 07, 2019
Canvas 1839 today publicly launched their first line of CBD products, available now for purchase online. The first two products offered are a clean, luxurious 500mg Relief Cream and a 300mg Relief Oil. Canvas 1839 products are formulated with a focus on high bioavailability, and are completely non-psychoactive.
All of Canvas 1839’s products are sourced from the highest quality Colorado-grown hemp available, and each batch produced undergoes additional testing beyond the legal requirement. Test results are included in every purchased package.
The team plans to expand their product offerings in the coming months with exciting partnerships with several of Austin’s retailers and collaborations with Austin originals.
“We have an awesome opportunity to help people live better. One that comes with an awesome responsibility, too. We’re grateful to be backed by a group of proven entrepreneurs and to have built a world-class team. We’re leading with exceptional science and are in this for the long-haul,” said Jason Luce, CEO and co-founder of Canvas 1839. “Outside of our own company walls, we are incredibly inspired by the city we live in. Austin is home to the nation’s creative class. We think this city’s soul and spirit are something worth carrying with us – and beyond us – through great products and experiences.”
The Canvas 1839 team is made up of entrepreneurs, wellness experts, and scientists from traditional industries with strong track records building technology companies, product companies, and brands.
CEO Jason Luce is an Austin-native and tech industry veteran who helped take Rackspace public in 2008. Co-founder Laura Komkov is a leading expert on CBD, who’s own personal journey led her to start Canvas 1839 with a goal of bringing the benefits of CBD’s restorative power to people everywhere.
The science team is led by Chief Science Officer, Dr. Kyle Hammerick, whose pioneering work in nanoscale biology has numerous applications in CBD. With over 15 years’ experience in medical device, pharmaceutical development, and drug delivery, Dr. Hammerick saw an opportunity to expand cannabinoid efficacy by getting the therapeutics to the right place, at the right time, in the right amount.
“Right now, there is a dearth of products and companies that have taken the time to build a foundation of science that supports their products,” said Dr. Kyle Hammerick, PhD, Chief Science Officer of Canvas 1839. “I have spent the last ten years studying healing, and the best way to create a consistent, efficacious products for every customer. At the end of the day we want to help people with good products that they can trust. That’s why our work is driven by science.”
CBD’s health benefits are related to their ability to act upon the body’s endocannabinoid system (ECS). When something throws the body out of homeostasis, or a state of balance, the ECS helps course-correct so that each individual can operate at their best possible level. Generally, our bodies are very good at managing this process.
However, in some cases, scientists believe there are not enough naturally occurring cannabinoids within the body for the endocannabinoid system to work effectively. The introduction of external, non-psychotropic cannabinoids like CBD could actually help counteract that deficit and be useful in treating certain ailments.
The industry is currently expanding the scope of what is known and understood about the benefits of hemp-derived products through on-going research and present and future clinical trials.
“We believe in products that nurture who we are, and allow us to feel good - not only in how we look, but also in general well-being, mental health - something that helps us thrive and heal at our core, ” said Laura Komkov, VP of Product at Canvas 1839. “Many people are just discovering the benefits of this compound, and many still have questions about its benefits and about what is good and what is not. That’s why we started this company with a commitment to build products that people can trust, rooted in transparency and authenticity."
About the products:
Canvas 1839 sources only USA-grown hemp cannabinoids that contain no pesticides, no parabens, no herbicides, no GMOs and no known major allergens. Canvas 1839 does not test its products on animals.
Canvas 1839 Relief Cream (500MG hemp-derived CBD per 2.0oz bottle, less than 0.3% THC): The luxurious relief cream is specifically formulated for optimal transdermal penetration and absorption, leaving a clean skin feel and no residue whatsoever.
Canvas 1839 Relief Oil (300MG full-spectrum hemp oil per 1.0oz bottle, less than 0.3% THC): The Relief Oil is crafted with Colorado-grown full-spectrum hemp extract containing naturally-occurring CBD, as well as over 100 additional cannabinoids, terpenes, and other plant compounds that support your well-being.
Canvas 1839 also offers a CBD starter pack that couples the systemic effects of the Relief Oil with the local effects of the Relief Cream. The pack contains one Relief Oil and one Relief Cream.
About Canvas 1839
Canvas 1839 is a community brought together by the restorative power of Hemp Cannabidiol (CBD). We believe deeply in the ritual of wellness. Every day, we strive to take care of ourselves, each other, and the world around us.
Through collaborations with Austin originals, we highlight new creative perspectives on modern health and wellness, harnessing nature’s original medicine with modern recipes.
Canvas 1839 creates the most bioavailable product on the market today. Our revolutionary molecular Uptake Ph.D TM ensures that all our products are consistently faster absorbing and faster acting than any other brand. We help you cultivate balance along multiple dimensions in the mind and body, be it better sleep, improved focus, or eased muscles and joints, so that you can get back to life.
Our products are made with 100% ultra-potent, pharmaceutical-grade CBD and are never psychoactive. Canvas 1839 products contain very low and legal concentrations of THC (0.3% or less.). Our scientific research and development is led by Chief Science Officer and Stanford grad Dr. Kyle Hammerick, whose pioneering work in Nanoscale Biology has myriad applications in CBD.
Canvas 1839. Original Medicine.